Cumberland Pharmaceuticals (CPIX) Net Income towards Common Stockholders Growth (1y) (2011 - 2026)
Cumberland Pharmaceuticals (CPIX) Net Income towards Common Stockholders Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | -304.98% |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | -5.04% |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | -17.29% |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 7.59% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -2,482.61% |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 34.33% |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | 390.91% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 116.48 Mn | 112.62 Mn | - | -481.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -151.71% |
| Mar 31, 2026 | -351.64% |
| Dec 31, 2025 | 25.57% |
| Sep 30, 2025 | -26.81% |
| Jun 30, 2025 | 33.32% |
| Mar 31, 2025 | 165.61% |
| Dec 31, 2024 | 69.82% |
| Sep 30, 2024 | -44.56% |
| Jun 30, 2024 | -227.89% |
| Mar 31, 2024 | -1,204.25% |
| Dec 31, 2021 | -42.28% |
| Sep 30, 2021 | -36.14% |
| Jun 30, 2021 | -32.47% |
| Mar 31, 2021 | -39.46% |
| Dec 31, 2020 | -63.62% |
| Sep 30, 2020 | -42.35% |
| Jun 30, 2020 | -4.29% |
| Mar 31, 2020 | -28.67% |
| Dec 31, 2019 | 139.82% |
| Sep 30, 2019 | 181.09% |